The Last Word: Macrocyclics Founder Dr. A. Dean Sherry on His Company’s Impact on Nuclear Medicine
- crosswindcommunicati
- Jul 14, 2023
- 1 min read
Dr. A. Dean Sherry [Photo: UT Dallas]
Dr. Sherry retired from UT Dallas last summer after decades of innovative work as one of its most distinguished chemistry professors. In 1995 he founded Macrocyclics on the campus, a company that continues to produce chemical compounds for the pharmaceutical industry and researchers around the globe.
A holder of 34 patents, Sherry was a pioneer in designing molecular materials for use in medical imaging.